TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NP34925a Hepatitis B immunoglobulin intramuscular use (IM)

Pharmaceutical products
Scotland (UKM)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP34925a Hepatitis B immunoglobulin intramuscular use (IM)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published2 May 2025, 13:34 BST
Last source update2 May 2025, 13:34 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
Scotland (UKM)
OCIDocds-h6vhtk-05027f
What is being bought
Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.
What changed
From the official release history
  1. Official notice release published
    2 May 2025, 13:34 BST
  2. Status changed to complete
    14 Apr 2025, 13:30 BST
  3. Official notice release published
    14 Apr 2025, 13:30 BST
  4. Buyer information updated
    14 Apr 2025, 13:30 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Framework Agreement is for the supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    2 May 2025, 13:34 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 30 Apr 2025, 00:00 BST · £549,120
Commercial outcome and competition
Awards
Bio Products Laboratory
Not published · Not published · active
Contracts
Contract
£549,120 · signed 30 Apr 2025, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
electronicBids: 1 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 1 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authority GB-FTS-115937
View buyer profile

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
    buyer
    centralPurchasingBody

    1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
    holly.bryce@nhs.scot
    +44 1312756000

  • Bio Products Laboratory
    supplier

    Dagger Lane, Elstree, Hertfordshire, UK, WD6 3BX

  • Sheriff Court House
    reviewBody

    27 Chambers Street, Edinburgh, EH1 1LB
    edinburgh@scotcourts.gov.uk
    +44 1312252525
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleAlthough Hepatitis B immunoglobulin intramuscular use (IM) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.